{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:01:53Z","timestamp":1762866113156},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/rhu.0b013e3182314d40","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T11:39:46Z","timestamp":1356003586000},"page":"349-355","source":"Crossref","is-referenced-by-count":41,"title":["An Audit of the Variability of Diagnosis and Management of Gout in the Rheumatology Setting"],"prefix":"10.1097","volume":"17","author":[{"given":"Fernando","family":"Perez-Ruiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jes\u00fas Garc\u00eda","family":"Y\u00e9benes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliseo","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Ure\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-1-20210207","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.bor.0000162060.25895.a5","article-title":"Recent advances in the management of gout and hyperuricemia.","volume":"17","author":"Wortmann","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"R3-1-20210207","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11926-996-0046-y","article-title":"Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?","volume":"7","author":"Mikuls","year":"2005","journal-title":"Curr Rheumatol Rep"},{"key":"R4-1-20210207","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R5-1-20210207","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R6-1-20210207","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1017\/S0266462303000497","article-title":"Factors influencing adherence to guidelines in general practice.","volume":"19","author":"Stewart","year":"2003","journal-title":"Int J Technol Assess Health Care"},{"key":"R7-1-20210207","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s100670050005","article-title":"How is gout managed in primary care? A review of current practice and proposed guidelines.","volume":"19","author":"Pal","year":"2000","journal-title":"Clin Rheumatol"},{"key":"R8-1-20210207","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1440-1762.2000.00353.x","article-title":"Quality use of allopurinol in the elderly.","volume":"20","author":"Smith","year":"2000","journal-title":"J Qual Clin Pract"},{"key":"R9-1-20210207","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1445-5994.2000.tb00857.x","article-title":"The optimal use of allopurinol: an audit of allopurinol use in South Auckland.","volume":"30","author":"Stamp","year":"2000","journal-title":"Aust N Z J Med"},{"key":"R10-1-20210207","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/rheumatology\/41.5.503","article-title":"Improving the quality of care of musculoskeletal conditions in primary care.","volume":"41","author":"Roberts","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"R11-1-20210207","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1001\/archinte.1993.00410240099012","article-title":"Gout and pseudogout in hospitalized patients.","volume":"153","author":"Ho","year":"1993","journal-title":"Arch Intern Med"},{"key":"R12-1-20210207","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7326\/0003-4819-127-1-199707010-00009","article-title":"Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: a critical review of the literature and proposed methodologic standards.","volume":"127","author":"Solomon","year":"1997","journal-title":"Ann Intern Med"},{"key":"R13-1-20210207","first-page":"104","article-title":"Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study.","volume":"33","author":"Neogi","year":"2006","journal-title":"J Rheumatol"},{"key":"R14-1-20210207","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/ard.2007.071530","article-title":"International survey on the diagnosis and management of gout.","volume":"66","author":"Doherty","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R15-1-20210207","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/ard.2007.085902","article-title":"Survey on management of gout among Dutch rheumatologists.","volume":"67","author":"Reinders","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R16-1-20210207","first-page":"2050","article-title":"A survey of current evaluation and treatment of gout.","volume":"33","author":"Schlesinger","year":"2006","journal-title":"J Rheumatol"},{"key":"R17-1-20210207","first-page":"2041","article-title":"The management of gout at an academic healthcare center in Beijing: a physician survey.","volume":"33","author":"Fang","year":"2006","journal-title":"J Rheumatol"},{"key":"R18-1-20210207","first-page":"1841","article-title":"A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario.","volume":"15","author":"Bellamy","year":"1988","journal-title":"J Rheumatol"},{"key":"R19-1-20210207","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/rheumatology\/40.9.1060","article-title":"The utilization of synovial fluid analysis in the UK.","volume":"40","author":"Amer","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"R20-1-20210207","first-page":"1566","article-title":"Treatment of acute gout in hospitalized patients.","volume":"34","author":"Petersel","year":"2007","journal-title":"J Rheumatol"},{"key":"R21-1-20210207","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/art.1780291209","article-title":"Monosodium urate crystals in the knee joints of patients with asymptomatic nontophaceous gout.","volume":"29","author":"Bomalaski","year":"1986","journal-title":"Arthritis Rheum"},{"key":"R22-1-20210207","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.1780250215","article-title":"Aspiration of the asymptomatic metatarsophalangeal joint in gout patients and hyperuricemic controls.","volume":"25","author":"Rouault","year":"1982","journal-title":"Arthritis Rheum"},{"key":"R23-1-20210207","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7326\/0003-4819-131-10-199911160-00007","article-title":"Synovial fluid analysis for diagnosis of intercritical gout.","volume":"131","author":"Pascual","year":"1999","journal-title":"Ann Intern Med"},{"key":"R24-1-20210207","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/ard.2007.073460","article-title":"First metatarsophalangeal joint aspiration using a 29-gauge needle.","volume":"67","author":"Sivera","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R25-1-20210207","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"R26-1-20210207","first-page":"264","article-title":"Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout.","volume":"18","author":"Wallace","year":"1991","journal-title":"J Rheumatol"},{"key":"R27-1-20210207","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/art.20102","article-title":"Quality of care indicators for gout management.","volume":"50","author":"Mikuls","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R28-1-20210207","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bmj.324.7352.1488","article-title":"Randomised double blind trial of etoricoxib and indomethacin in treatment of acute gouty arthritis.","volume":"324","author":"Schumacher","year":"2002","journal-title":"BMJ"},{"key":"R29-1-20210207","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? The results of the first controlled study in acute gout.","volume":"17","author":"Ahern","year":"1987","journal-title":"Aust N Z J Med"},{"key":"R30-1-20210207","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/ard.2007.070755","article-title":"Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.","volume":"66","author":"Roddy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R31-1-20210207","first-page":"341","article-title":"Gout: epidemiology and lifestyle choices.","volume":"17","author":"Choi","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"R32-1-20210207","first-page":"773","article-title":"Gout: excess calories, purines, and alcohol intake and beyond. Response to a urate-lowering diet.","volume":"32","author":"Fam","year":"2005","journal-title":"J Rheumatol"},{"key":"R33-1-20210207","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.22466","article-title":"Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey.","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R34-1-20210207","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0002-9343(74)90634-2","article-title":"Milestones in the treatment of gout.","volume":"56","author":"Yu","year":"1974","journal-title":"Am J Med"},{"key":"R35-1-20210207","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","article-title":"British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.","volume":"46","author":"Jordan","year":"2007","journal-title":"Rheumatology (Oxford)"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RHU.0b013e3182314d40","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:56:20Z","timestamp":1620971780000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-201110000-00001"}},"subtitle":["The Gout Evaluation and Management Study"],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e3182314d40","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}